Effectiveness of Conditioning + Open-label Placebo for the Management of Pain in Children Who Undergo Surgical Treatment of Idiopathic Scoliosis.

A clinical trial, NCT06365892, is set to begin on May 1, 2024, and is expected to be completed on January 1, 2026. The trial aims to investigate the effects of conditioning with open-label placebos on postoperative treatment for patients undergoing surgery for idiopathic scoliosis. The study will involve 64 patients who will be randomly assigned to either the open-label placebo group or the treatment as usual group. Data will be collected from medical records and surveys to assess pain, mobility, anxiety, depressive symptoms, and other outcomes. The study aims to provide insights into the potential benefits of open-label placebos in managing pain and improving outcomes for patients with idiopathic scoliosis. [Extracted from the article]

Copyright of Women's Health Weekly is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)